Watch as Dr. Thomas Zeller reviews his presentation on the treatment of symptomatic femoropopliteal disease with drug-coated balloons vs bare-metal stents, which he gave at the Amputation Prevention Symposium in August 2023.
Drs Lobato and Ysa review the article "A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia” by Nagarsheth et al.
Drs Lobato and Ysa review the article "A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia” by Nagarsheth et al.
Anthony Pham, BS; Geoff Thomas, BS; Vivie Tran, MS; Dixon Santana, MD; Sahil A. Parikh, MD, FACC, FSCAI; Subhash Banerjee, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Fadi Saab, MD, FACC, FSCAI; Jihad A. Mustapha, MD, FACC, FSCAI; Mohammad M. Ansari, MD
The authors seek to explore the representation of minority groups and women in clinical studies evaluating the usage of drug-coated balloons for treatment in PAD/CLTI.
The authors seek to explore the representation of minority groups and women in clinical studies evaluating the usage of drug-coated balloons for treatment in PAD/CLTI.
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.